An unusual strategy lets you virtually "recreate" gains off the biggest companies you thought had come and gone. CLICK HERE to see how it works.
Earnings Optimism Hides Ugly Truth
by The Investment U Research Team
The mood seems to have soured on Wall Street since its bounce early this morning. And if you peer beneath the headlines, you can see why. The big news has been Caterpillar’s (NYSE: CAT) earnings, which tripled analyst’s expectations.
But as we look deeper, we find that CAT’s earnings are well below last year’s figures.
Merck (NYSE: MRK) announced that earnings dropped less than expected. Again, note revenue still dropped 2%. State Street (NYSE: STT) reported a loss of almost $3.3 billion as it writes down asset values. Coca-Cola (NYSE: KO) also announced lower earnings, citing stronger dollar.
On the surface, these earnings reports sound good, but they hide the ugly truth.
And the list goes on, from BlackRock (NYSE: BLK), Freeport-McMoRan (NYSE: FCX) to Comerica (NYSE: CMA) and E.I. du Pont Nemours (NYSE: DD).
Almost every company that we could find reporting earnings today had headlines of proclaiming increased earnings. The sad fact is that these companies have done little more than beat the underestimated numbers of a bunch of Wall Street analysts who weren’t expecting much.
The reality is that while positive, these numbers cover up the sad state of earnings and profits right now. And at the end of the day, earnings are what matter.
Symbols mentioned in this article: CAT, MRK, STT, KO, BLK, FCX, CMA and DD.
- FedEx Miss Spooks Wall Street
- DOW Chemical Cuts Back on Almost Everything
- HIG and GNW: Wolves in Bank Sheepskins?
|
The Company Set to Dominate a $60 Billion-a-Year Market
$60 billion is spent on cancer treatment in the U.S. - each year. And one company is poised to receive the lion's share of it.
The medical director at the Alta Bates Comprehensive Cancer Center says, "...possibly a third of our cancer patient population will soon be undergoing this [company's] treatment."
Another doctor at the University of Texas MD Anderson Cancer Center says he intends to treat over 1,000 patients a year with this technology.
Here's how you can claim your stake in the company before this cash infusion sends shares soaring.
Comments
**By submitting your comment you agree to adhere to our Comment Policy and Privacy Policy.Check out our selection of daily Investment Research:
![]() |
![]() |











Investment U RSS Feed